Localized mucosal response to intranasal live attenuated influenza vaccine in adults

Maria Ines Barría, Jose Luis Garrido, Cheryl Stein, Erica Scher, Yongchao Ge, Stephanie M. Engel, Thomas A. Kraus, David Banach, Thomas M. Moran

Research output: Contribution to journalArticlepeer-review

75 Scopus citations


Background. Influenza virus infection is a major public health burden worldwide. Available vaccines include the inactivated intramuscular trivalent vaccine and, more recently, an intranasal live attenuated influenza vaccine (LAIV). The measure of successful vaccination with the inactivated vaccine is a systemic rise in immunoglobulin G (IgG) level, but for the LAIV no such correlate has been established. Methods. Seventy-nine subjects were given the LAIV FluMist. Blood was collected prior to vaccination and 3 days and 30 days after vaccination. Nasal wash was collected 3 days and 30 days after vaccination. Responses were measured systemically and in mucosal secretions for cytokines, cell activation profiles, and antibody responses. Results. Only 9% of subjects who received LAIV seroconverted, while 33% of patients developed at least a 2-fold increase in influenza virus-specific immunoglobulin A (IgA) antibodies in nasal wash. LAIV induced a localized inflammation, as suggested by increased expression of interferon-response genes in mucosal RNA and increased granulocyte colony-stimulating factor (G-CSF) and IP-10 in nasal wash. Interestingly, patients who seroconverted had significantly lower serum levels of G-CSF before vaccination. Conclusions. Protection by LAIV is likely provided through mucosal IgA and not by increases in systemic IgG. LAIV induces local inflammation. Seroconversion is achieved in a small fraction of subjects with a lower serum G-CSF level.

Original languageEnglish
Pages (from-to)115-124
Number of pages10
JournalJournal of Infectious Diseases
Issue number1
StatePublished - 1 Jan 2013


  • FluMist
  • G-CSF
  • IP10
  • Influenza
  • Interferon
  • LAIV
  • Vaccination


Dive into the research topics of 'Localized mucosal response to intranasal live attenuated influenza vaccine in adults'. Together they form a unique fingerprint.

Cite this